机构地区:[1]河南省疾病预防控制中心健康教育与慢性非传染性疾病防治研究所,河南省郑州450000 [2]河南省肿瘤医院郑州大学附属肿瘤医院
出 处:《中华预防医学杂志》2012年第12期1084-1087,共4页Chinese Journal of Preventive Medicine
基 金:河南省医学重点学科、临床特色专科学术技术带头人培养计划项目(201018-66);卫生部中央补助地方农村地区癫痫防治管理项目(财社[2006]126号)
摘 要:目的探讨癫痫患者的疾病经济负担状况及其影响因素。方法采用多阶段分层随机抽样的方法,自2005年1月至2011年7月在河南省焦作市的孟州市、修武县,漯河市的郾城区、源汇区、舞阳县、临颍县、召陵区,南阳市的新野县和方城县9个项目示范点,对综合干预组(422例)、无干预对照组(452例)的共874例癫痫患者现场问卷调查,采用伤残调整生命年(DALY)指标从直接经济负担和间接经济负担两个方面结合人力资本法来测算患者的疾病经济负担。结果在874例调查对象中,综合干预组年龄为(43.7±8.5)岁,无干预对照组年龄为(44.4±7.2)岁,两组年龄差异无统计学意义(P=0.365)。调查对象人均直接经济负担为1019.6形年,其中癫痫药费434.2元/年,干预组分别为485.2、66.4形年,对照组分别为1518.5、777.5形年。调查对象人均损失(16.67±10.01)个DALY,干预组人均损失8.58个DALY,无干预对照组人均损失24.23个DALY。干预组和对照组的人均间接经济负担分别为68115.2、401036.5元,人均总疾病经济负担为68600.5、408755.0元。调查对象人均疾病经济负担为244515.6元。多因素logistic回归分析结果显示,病程(以0~9年组为对照)为≥37、30~36、20~29、10~19个月者OR(95%吖)值分别为4.44(2.37~8.33)、3.32(1.85~5.94)、3.25(1.90~5.56)、2.53(1.46~4.41),病程越长,患者疾病经济负担越严重;服药依从性差者(以依从性好者为对照)的OR(95%C1)值为3.37(2.34~4.83),服单药者(以服多药者为对照)的OR(95%CI)值为0.41(0.29~0.59),服单药和依从性好者疾病经济负担较轻。结论癫痫造成严重的经济损害,病程长、服药依从性差及服多药者疾病经济负担更重;综合性干预可以更好地降低癫痫患者的�Objective To analyze the various factors affecting the economic burden of disease in patients with epilepsy. Methods This research used a multi-stage random sampling method, comprehensive intervention and without intervention of the epilepsy project group conducted a field survey of health examination among patients with epilepsy of 874 (422 cases in intervention group and 452 cases in control group) in Mengzhou, Xiuwu, Yancheng, Yuanhui, Wuyang, Linying, Shaoling, Xinye and Fangcheng. DALY indicators combined with human capital approach was used to measure the economic burden of disease in patients fi'om two aspects of the direct economic burden and indirect economic burden. Results The age of comprehensive intervention group was (43.7 ± 8.5)years old, and it was (44. 4 ± 7.2)years old in no intervention control group. The age difference was not statistically significant ( P = 0. 365 ). The direct economic burden per capita of the survey was 1019.6 yuan per year, while epilepsy drugs 434. 2 yuan per year, 485.2 and 66.4 yuan per year in the intervention group, while 1518.5 and 777.5 yuan per year in the control group. Each object in this study lost ( 16. 67 ± 10. 01 ) DALY, with 8.58 DALY in intervention group and 24. 23 DALY in no intervention control group. The per capita indirect economic burden of the intervention and control groups were 68 115.2, 401 036. 5 yuan, the per capita total economic burden of disease were 68 600. 5, 408 755.0 yuan. Multivariate logistic regression analysis showed that disease duration year of ≥ 37, 30 - 36, 20 - 29, 10 - 19, OR (95 % CI) were 4. 44 ( 2. 37 - 8.33 ), 3.32 ( 1.85 - 5.94) , 3.25 ( 1.90 - 5.56), 2. 53 ( 1.46 - 4. 41 ). If patients with longer duration, the more serious the patient's disease burden. Medication compliance (in order to comply with a good group control) 0R(95% CI) was 3.37 ( 2. 34 - 4. 83 ), medication in the single form ( serving multi-drug groups for control) OR (95% CI) O. 41 (0. 29
分 类 号:R742.1[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...